现货供应对照品Fondaparinux C13683 上海佰世凯化学科技有限公司

现货供应对照品Fondaparinux sodium(D01844)/磺达肝癸钠

如果您对该产品感兴趣的话，可以
产品名称：现货供应对照品Fondaparinux sodium(D01844)/磺达肝癸钠
产品型号：C13683
产品展商：Chembest
产品文档：无相关文档

简单介绍

产品描述

Chemical Name: decasodium (2R,3S,4S,5R,6R)-3-[(2R,3R,4R,6R)-5-[(2R,3R,4S,5S,6S)-6-carboxylato-5-[(2R,3R,4R,5S,6R)-4,5-dihydroxy-3-(sulfonatoamino)-6-(sulfonatooxymethyl)oxan-2-yl]oxy-3,4-dihydroxy-oxan-2-yl]oxy-3-(sulfonatoamino)-4-sulfonatooxy-6-(sulfonatooxymethyl)oxan-2-yl]oxy-4-hydroxy-6-[(2R,3S,4R,5R,6S)-4-hydroxy-6-methoxy-5-(sulfonatoamino)-2-(sulfonatooxymethyl)oxan-3-yl]oxy-5-sulfonatooxy-oxane-2-carboxylate
别名：Arixtra,D0184
英文名：Fondaparinux sodium
分子式：C31H43N3Na10O49S8
分子量：1728.08
纯度：>98%
CAS：114870-03-0
Biological Activity:
Antithrombotic, indirect and selective synthetic factor Xa inhibitor; Fondaparinux is a synthetic and specific inhibitor of activated Factor X (Xa) with no animal sourced components. The anti-thrombotic activity of fondaparinux is the result of antithrombin III (ATIII) mediated selective inhibition of Factor Xa. By binding selectively to ATIII, fondaparinux potentiates (about 300 times) the innate neutralisation of Factor Xa by antithrombin. Neutralisation of Factor Xa interrupts the blood coagulation cascade and inhibits both thrombin formation and thrombus development. Fondaparinux does not inactivate thrombin (activated Factor II) and has no effects on platelet aggregation. It does not cross-react with sera from patients with heparin-induced thrombocytopenia. At the recommended dose, it does not affect fibrinolytic activity or bleeding time. At equivalent anti-thrombotic doses, an experimental bleeding model in rats demonstrates that fondaparinux induces less bleeding than unfractionated heparin.

产品留言

标题

联系人

联系电话

内容

验证码

点击换一张

注：1.可以使用快捷键Alt+S或Ctrl+Enter发送信息!
2.如有必要,请您留下您的详细联系方式!

温馨提示：为规避购买风险，建议您在购买前务必确认供应商资质与产品质量。
免责申明：以上内容为注册会员自行发布，若信息的真实性、合法性存在争议，平台将会监督协助处理，欢迎举报

产品目录

产品资料

现货供应对照品Fondaparinux sodium(D01844)/磺达肝癸钠